We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$10.4B
AUM Growth
+$973M
Cap. Flow
+$812M
Cap. Flow %
7.81%
Top 10 Hldgs %
48.6%
Holding
224
New
70
Increased
35
Reduced
44
Closed
43

Top Buys

Rank Stock Value
1
THI
TIM HORTONS INC COM, CANADA
THI
+$454M
2
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$430M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$290M
4
OUT icon
Outfront Media
OUT
+$150M
5
BRSL
Brightstar Lottery PLC
BRSL
+$145M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$867M
2
FRX
FOREST LABORATORIES INC
FRX
+$179M
3
HSH
HILLSHIRE BRANDS CO
HSH
+$172M
4
WY icon
Weyerhaeuser
WY
+$88.7M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$79.1M

Sector Composition

Rank Sector Weight
1 Healthcare 15.69%
2 Technology 9.71%
3 Consumer Discretionary 8.68%
4 Communication Services 4.96%
5 Materials 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
51
State Street SPDR S&P 500 ETF Trust
SPY
$826B
$38.2M 0.37%
194,000
+154,000
+385% +$30.4M
NPSP
52
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$36.4M 0.35%
1,398,200
+1,038,200
+288% +$29.8M
COV
53
PUT
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$32.9M 0.32%
380,000
+280,000
+280% +$24.8M
MONT
54
DELISTED
MONTAGE TECHNOLOGY GROUP LTD
MONT
$31.4M 0.3%
1,502,957
+1,457
+0.1% +$31K
TLM
55
DELISTED
TALISMAN ENERGY INC
TLM
$31.1M 0.3%
+3,600,000
New +$36.3M
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
$29.5M 0.28%
650,000
+72,200
+12% +$3.02M
SYF icon
57
Synchrony
SYF
$25.8B
$29M 0.28%
+1,180,000
New +$28.8M
BHC icon
58
PUT
Bausch Health
BHC
$2.34B
$28.9M 0.28%
220,000
-100,000
-31% -$11.9M
BKW
59
DELISTED
BURGER KING WORLDWIDE
BKW
$27.5M 0.26%
+928,400
New +$26.5M
TPH
60
DELISTED
Tri Pointe Homes
TPH
$26.9M 0.26%
+2,075,000
New +$29.5M
EBIX
61
DELISTED
Ebix Inc
EBIX
$26.8M 0.26%
1,892,000
+172,000
+10% +$2.39M
S
62
CALL
DELISTED
Sprint Corporation
S
$26.6M 0.26%
4,200,000
-1,000,000
-19% -$6.81M
NPSP
63
PUT
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$26.3M 0.25%
1,010,000
+510,000
+102% +$14.6M
LYB icon
64
LyondellBasell Industries
LYB
$19.5B
$26.1M 0.25%
240,000
-430,000
-64% -$46.5M
SHPG
65
PUT
DELISTED
Shire pic
SHPG
$25.9M 0.25%
+100,000
New +$24.8M
GTIV
66
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$25.2M 0.24%
1,500,000
+930,916
+164% +$16.3M
ESPR
67
DELISTED
Esperion Therapeutics
ESPR
$24.2M 0.23%
990,000
-10,000
-1% -$159K
LO
68
CALL
DELISTED
LORILLARD INC COM STK
LO
$24M 0.23%
400,000
+100,000
+33% +$6.06M
ANF icon
69
Abercrombie & Fitch
ANF
$4.98B
$23.6M 0.23%
650,000
+290,000
+81% +$11.8M
AZN icon
70
PUT
AstraZeneca
AZN
$250B
$23.6M 0.23%
330,000
-1,260,000
-79% -$92.2M
DRC
71
DELISTED
DRESSER-RAND GROUP INC
DRC
$22.3M 0.21%
+271,328
New +$18.2M
PETM
72
DELISTED
PETSMART INC
PETM
$21M 0.2%
+300,000
New +$20.9M
KYTH
73
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$20.3M 0.2%
619,400
+8,710
+1% +$307K
ABBV icon
74
PUT
AbbVie
ABBV
$431B
$20.2M 0.19%
+350,000
New +$19.4M
BYD icon
75
Boyd Gaming
BYD
$6.37B
$18.9M 0.18%
1,860,000
+1,580,000
+564% +$17.1M
1 2
3
4 5

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Pentwater Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Pentwater Capital Management held 224 positions worth $10.4B, up 10% from $9.42B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Pentwater Capital Management deployed $812M of net new capital in Q3 2014, opening 70 new positions and adding to 35 existing holdings. Its largest new stake was TIM HORTONS INC COM, CANADA: 6,797,200 shares worth $536M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Paramount Global Class B, an estimated $867M trimmed.

  • Pentwater Capital Management's largest Q3 2014 buy was TIM HORTONS INC COM, CANADA: 6,797,200 shares worth $536M.
  • Pentwater Capital Management added most to Outfront Media in Q3 2014, an estimated $150M increase.
  • Pentwater Capital Management's biggest Q3 2014 reduction was Paramount Global Class B, cutting an estimated $867M.
  • Pentwater Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $179M.
  • Pentwater Capital Management's ten largest holdings make up 49% of its $10.4B portfolio in Q3 2014.
  • Pentwater Capital Management opened 70 new positions and closed 43 in Q3 2014.
  • Pentwater Capital Management's portfolio value rose 10% quarter-over-quarter to $10.4B.

Based on Pentwater Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.